Immune monitoring after NKTR-214 plus nivolumab (PIVOT-02) in previously untreated patients with metastatic stage IV melanoma
Diab, A Tykodi, S Curti, B Cho, D Wong, M Puzanov, I Lewis, K Maio, M Daniels, G Spira, A
Diab, A
Tykodi, S
Curti, B
Cho, D
Wong, M
Puzanov, I
Lewis, K
Maio, M
Daniels, G
Spira, A
Citations
Altmetric:
Abstract
Authors
Diab, A
Tykodi, S
Curti, B
Cho, D
Wong, M
Puzanov, I
Lewis, K
Maio, M
Daniels, G
Spira, A
Tagliaferri, M
Hannah, A
Clemens, W
Imperiale, M
Bernatchez, C
Haymaker, C
Bentebibel, S
Zalevsky, J
Hoch, U
Fanton, C
Rizwan, A
Aung, S
Cattaruzza, F
Iaccucci, E
Sawka, D
Bilen, M
Lorigan, Paul C
Grignani, G
Larkin, J
Jang, S
Warzocha, E
Sznol, M
Hurwitz, M
Tykodi, S
Curti, B
Cho, D
Wong, M
Puzanov, I
Lewis, K
Maio, M
Daniels, G
Spira, A
Tagliaferri, M
Hannah, A
Clemens, W
Imperiale, M
Bernatchez, C
Haymaker, C
Bentebibel, S
Zalevsky, J
Hoch, U
Fanton, C
Rizwan, A
Aung, S
Cattaruzza, F
Iaccucci, E
Sawka, D
Bilen, M
Lorigan, Paul C
Grignani, G
Larkin, J
Jang, S
Warzocha, E
Sznol, M
Hurwitz, M
Affiliation
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Diab A, Tykodi S, Curti B, Cho D, Wong M, Puzanov I, et al. Immune monitoring after NKTR-214 plus nivolumab (PIVOT-02) in previously untreated patients with metastatic stage IV melanoma. 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018); Nov 6; Washington, D.C., USA. 7-11 November 2018. J Immunother Cancer. 2018. p. 115.